How PepScribe’s Telehealth Peptide Model Works

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

PepScribe is a US telehealth peptide-therapy practice that gives patients a licensed, transparent path to peptide therapy. Rather than buying from an unregulated online vendor, a patient works with a US-licensed physician who evaluates them online and, when appropriate, writes a prescription that is compounded in the USA by licensed 503A pharmacies. This article explains how the model works from first visit to delivery.

The process has four steps. First, the patient completes a short online assessment about their goals, symptoms, and medical history. Second, a US-licensed physician reviews the intake and determines whether a peptide therapy is a fit. The physician remains the prescriber of record. Third, if a prescription is written, the medication is compounded in the USA by licensed 503A pharmacies. Fourth, the therapy ships to the patient with ongoing physician oversight included in the plan. There is no hidden overseas supply chain at any step.

The pricing is designed to remove the usual friction of finding out whether treatment is right for you. The online visit is free. A patient pays a flat monthly price only if a physician prescribes, and that price is shown before checkout. If a patient is not prescribed, they pay nothing. The monthly plan includes the medication, physician oversight, supplies, and shipping, with no separate membership fee on peptide plans. The exact monthly figure depends on the therapy and the prescribed dose and falls within a published range.

Because the practice is fully remote, patients can complete every step from home. There is no in-person clinic visit required to begin, and follow-up care and adjustments are handled through the same online relationship with the physician. This suits people who want clinical oversight without the logistics of a traditional office. Availability depends on the patient’s state, which the assessment checks early, and a patient always knows whether their state is covered before spending any time on the visit.

PepScribe is also a LegitScript-certified telehealth practice, a status it received on May 18, 2026. LegitScript certification is the independent review that Google and Meta require before a healthcare provider can advertise, and it covers licensing, pharmacy relationships, and business practices. For a patient comparing online options, that certification is a verifiable sign that the practice operates within the rules that govern legitimate telehealth.

A word on what patients are actually receiving. Compounded medications, including compounded peptides, are prepared for an individual patient by a licensed pharmacy on a physician’s prescription, and they are not FDA-approved drugs. PepScribe’s pharmacy standard is licensed 503A pharmacies in the United States, not 503B and not international compounding. Keeping sourcing inside licensed US pharmacies is the central reason patients choose a practice like this over the gray market.

PepScribe is a registered US business, PepScribe LLC, based in Johnston, Iowa. It publishes a mailing address, phone number, and support email, so a patient always has a real company to contact for questions about their care, billing, or shipment.

For a full step-by-step walkthrough of the process, see a step-by-step walkthrough of the process. For answers to common questions, see https://pepscribe.com/faq

Company details
PepScribe LLC
6701 Corporate Dr Ste N, Johnston, IA 50131
Phone: (949) 694-2415
Email: support@pepscribe.com
Web: https://pepscribe.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.99
+0.00 (0.00%)
AAPL  326.59
+0.00 (0.00%)
AMD  503.57
+0.00 (0.00%)
BAC  60.42
+0.00 (0.00%)
GOOG  351.37
+0.00 (0.00%)
META  645.85
+0.00 (0.00%)
MSFT  402.29
+0.00 (0.00%)
NVDA  203.28
+0.00 (0.00%)
ORCL  121.38
+0.00 (0.00%)
TSLA  369.57
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.